Aegis Therapeutics is a drug-delivery and drug-formulation technologies company commercializing its patented drug delivery and protein stabilization technologies through product specific licenses to leading pharmaceutical and biopharmaceutical companies.
SAN DIEGO, CA October 28, 2013 — Aegis Therapeutics LLC is proud to announce it is celebrating its 10-year anniversary on October 31, 2013. Aegis was founded by a renowned group of successful biotech entrepreneurs from the San Diego area to commercialize proprietary technologies that solve some of the most pressing drug delivery problems for […]
SAN DIEGO, CA October 9, 2013/MarketWired– Aegis Therapeutics LLC announced today that it has been awarded its first patent for non-invasive delivery of a protein drug to the central nervous system (CNS). U.S. Patent No. 8,551,468 provides drug compositions for non-invasive direct delivery of stabilized beta-interferon to the central nervous system via a simple metered […]
SAN DIEGO, CA September 4, 2013/PR Newswire – Two “super generic” drugs utilizing Aegis Therapeutics Intravail technology for treatment of migraine headaches and seizures are rapidly advancing through clinical trials under the FDA’s 505(b)2 pathway. Rapid relief of certain medical conditions is dependent upon early establishment of therapeutic blood levels of drug. Examples include drugs […]